RASSF1 and laryngotracheoesophageal cleft: Based on the analysis of DNA isolated from bronchial swabs of 333 LC patients and 323 healthy donors, Nikolaidis G. et al. identified a tumor-marker combination, including the regulatory regions of the TERT and RASSF1A genes, as the most informative for LC diagnosis[14].